Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Share-based Compensation (2016 - 2025)

INVO Fertility has reported Share-based Compensation over the past 15 years, most recently at $1.1 million for Q3 2025.

  • Quarterly Share-based Compensation rose 410.33% to $1.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $941017.0 through Sep 2025, up 330.93% year-over-year, with the annual reading at $153.0 for FY2024, 99.95% down from the prior year.
  • Share-based Compensation was $1.1 million for Q3 2025 at INVO Fertility, up from $11875.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $1.2 million in Q4 2022 and troughed at -$791647.0 in Q4 2021.
  • The 5-year median for Share-based Compensation is $79479.0 (2022), against an average of $163742.6.
  • Year-over-year, Share-based Compensation plummeted 374.11% in 2021 and then surged 76698.91% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at -$791647.0 in 2021, then skyrocketed by 252.64% to $1.2 million in 2022, then tumbled by 151.05% to -$616855.0 in 2023, then skyrocketed by 66.08% to -$209218.0 in 2024, then surged by 610.33% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Share-based Compensation are $1.1 million (Q3 2025), $11875.0 (Q2 2025), and $70655.0 (Q1 2025).